Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAMTS5 | Q9UNA0 | 18/20 | 0.76 |
| ▸ | SLC27A2 | O14975 | 1/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | XBP1 | P17861 | 1/20 | 0.52 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4355848 | 0.86 | ADAMTS5 (1.00) | ADAMTS5SLC27A2ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL12315872 | 0.84 | ADAMTS5 (0.55) | ADAMTS5SLC27A2ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL6272079 | 0.71 | ADAMTS5 (0.74) | ADAMTS5SLC27A2ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL24571119 | 0.71 | ADAMTS5 (0.74) | ADAMTS5SLC27A2ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL24571274 | 0.71 | ADAMTS5 (0.74) | ADAMTS5SLC27A2ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL4354096 | 0.71 | ADAMTS5 (1.00) | ADAMTS5SLC27A2ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL12315860 | 0.71 | ADAMTS5 (0.72) | ADAMTS5SLC27A2ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL4201238 | 0.70 | ADAMTS5 (1.00) | ADAMTS5SLC27A2ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL22571267 | 0.69 | ADAMTS5 (0.70) | ADAMTS5SLC27A2ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL22571281 | 0.69 | ADAMTS5 (0.70) | ADAMTS5SLC27A2ALDH1A1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8431582-B2 | Inhibitors of fatty acid uptake and methods of use | NUTECH VENTURES (US) | 2013-04-30 | — | — | US | disclosed |
| US-8410118-B2 | Inhibitors of fatty acid uptake and methods of use | NUTECH VENTURES (US) | 2013-04-02 | — | — | US | disclosed |
| US-20120309772-A1 | INHIBITORS OF FATTY ACID UPTAKE AND METHODS OF USE | NATIONAL INSTITUTES OF HEALTH | 2012-12-06 | — | — | US | disclosed |
| US-20120302585-A1 | INHIBITORS OF FATTY ACID UPTAKE AND METHODS OF USE | Nutech Ventures, a Nebraska corporation | 2012-11-29 | — | — | US | disclosed |
| US-8263640-B2 | Inhibitors of fatty acid uptake and methods of use | NUTECH VENTURES (US) | 2012-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120302585-A1 | INHIBITORS OF FATTY ACID UPTAKE AND METHODS OF USE | SLC27A2, SLC27A1, FABP4 | ADAMTS5 3277/4885SLC27A2 1/4885ALDH1A1 2034/4885 |
| US-20120309772-A1 | INHIBITORS OF FATTY ACID UPTAKE AND METHODS OF USE | SLC27A2, SLC27A1, FABP4 | ADAMTS5 3277/4885SLC27A2 1/4885ALDH1A1 2034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.